An overwhelming majority of U.S. adults (88%) say the benefits of the MMR vaccine outweigh the risks – the same share as in 2016, when the Center last asked this question – while the share who consider its preventive health benefits to be “very high” has grown by 11 percentage points during that time (from 45% to 88%).